# Bone Marrow Aspirate Concentrate Use in Hip Osteoarthritis

> **NCT03410355** · NA · TERMINATED · sponsor: **Nova Scotia Health Authority** · enrollment: 6 (actual)

## Conditions studied

- Osteoarthritis, Hip

## Interventions

- **PROCEDURE:** BMAC/PRP Injection
- **PROCEDURE:** Cortisone Injection

## Key facts

- **NCT ID:** NCT03410355
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-01
- **Primary completion:** 2019-05-17
- **Final completion:** 2019-05-17
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Health Canada no longer allowed use of BMAC
- **Last updated:** 2022-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03410355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03410355, "Bone Marrow Aspirate Concentrate Use in Hip Osteoarthritis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03410355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*